or Try an Advanced Search...

    Protein Kinase Inhibitor Stocks List

    Symbol Grade Name % Change
    ACLX D Arcellx, Inc. 4.32
    ALLR F Allarity Therapeutics, Inc. 7.87
    AVBP D ArriVent BioPharma, Inc. 1.03
    BBIO D BridgeBio Pharma, Inc. 5.50
    BPMC A Blueprint Medicines Corporation 3.85
    COGT D Cogent Biosciences, Inc. 6.62
    CRIS A Curis, Inc. 4.17
    DAWN A Day One Biopharmaceuticals, Inc. 3.45
    DCPH A Deciphera Pharmaceuticals, Inc. 0.36
    ELVN A Enliven Therapeutics, Inc. 4.08
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Cancer Tyrosine Kinase Biotechnology Tyrosine Kinase Receptors Biopharmaceutical Solid Tumors Acute Myeloid Leukemia Cancer Treatment Chronic Myeloid Leukemia Clinical Medicine Enzymes Her2 Myelodysplastic Syndrome Non Small Cell Lung Cancer Organ Systems Orphan Drug Small Molecule Therapies Treatment Of Cancer Achondroplasia Advanced Breast Cancer

    Related ETFs - A few ETFs which own one or more of the above listed Protein Kinase Inhibitor stocks.

    Symbol Grade Name Weight
    IDNA C iShares Genomics Immunology and Healthcare ETF 6.56
    CNCR C Loncar Cancer Immunotherapy ETF 5.89
    XBI C SPDR S&P Biotech ETF 3.63
    BBP C BioShares Biotechnology Products Fund 3.56
    FBT D First Trust Amex Biotech Index Fund 3.43
    View all Protein Kinase Inhibitor ETFs...
    Compare ETFs
    Compare BBP to FBT Compare CNCR to XBI Compare XBI to FBT

        Protein Kinase Inhibitor Stocks Recent News

        Date Stock Title
        May 1 BPMC Blueprint Medicines Q1 2024 Earnings Preview
        May 1 BBIO Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life
        Apr 30 BPMC Will Apellis Pharmaceuticals, Inc. (APLS) Report Negative Earnings Next Week? What You Should Know
        Apr 30 DCPH ONO to acquire Deciphera Pharmaceuticals in $2.4B deal
        Apr 30 CRIS Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024
        Apr 30 DCPH Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion
        Apr 29 DCPH Why Is Cancer Focused Deciphera Pharmaceuticals Stock Skyrocketing On Monday?
        Apr 29 DCPH Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
        Apr 29 DCPH Ono Pharmaceutical acquires cancer-focused biopharma Deciphera for $2.4bn
        Apr 29 DCPH Deciphera Agrees to $2.4 Billion Buyout Offer From Japan's ONO Pharmaceutical
        Apr 29 DCPH Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
        Apr 29 DCPH Deciphera Pharmaceuticals Is Being Acquired and the Stock Soars 72%
        Apr 29 ALLR Allarity regains compliance with NASDAQ minimum bid price requirement
        Apr 29 DCPH Update: Deciphera Pharmaceuticals to Be Acquired by ONO Pharmaceutical in $2.4 Billion Deal
        Apr 29 DCPH Deciphera stock soars after Ono Pharmaceutical’s $2.4B buyout deal
        Apr 29 DCPH Deciphera to sell for $2.4B, adding to upswing in biopharma M&A
        Apr 29 DCPH UPDATE 2-Japan's Ono to buy US drugmaker Deciphera for $2.4 bln
        Apr 29 DCPH Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
        Apr 29 ALLR Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement
        Apr 26 DCPH Diving Into Deciphera Pharmaceuticals
        Related Industries: Biotechnology
        Related Stock Lists: Cancer Tyrosine Kinase Biotechnology Tyrosine Kinase Receptors Biopharmaceutical Solid Tumors Acute Myeloid Leukemia Cancer Treatment Chronic Myeloid Leukemia Clinical Medicine Enzymes Her2 Myelodysplastic Syndrome Non Small Cell Lung Cancer Organ Systems Orphan Drug Small Molecule Therapies Treatment Of Cancer Achondroplasia Advanced Breast Cancer
        Protein Kinase Inhibitor

        Protein kinase inhibitors are drugs that block the activity of one or more protein kinases. Protein kinases are enzymes that add phosphate groups to proteins, which can alter their activity and function. Protein kinase inhibitors are used to treat a variety of diseases, including cancer, inflammation, and autoimmune disorders.

        Browse All Tags